CDK2 inhibition enhances CDK4/6 inhibitor antitumor activity in comprehensive breast cancer PDX model screen
Nealia C. House(Blueprint Medicines (United States))
Cited by 5
Related Papers
Site-specific targeting of a light activated dCas9-KIllerRed fusion protein generates transient, localized regions of oxidative DNA damage
|bioRxiv (Cold Spring Harbor Laboratory)|2020|2